Vous voyez ces citations basées sur la navigation précédente liée à des secteurs tels que
Nom | Valeur | 1 jour | 7 jour | 14 jour | 30 jour | 90 jour | bêta |
---|---|---|---|---|---|---|---|
4basebio | n / a | 0.00% | 3.38% | 12.63% | 11.46% | 63.98% | n / a |
Pharmacie 4D | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Abcam | 134 | 0.00% | -3.24% | -2.23% | -14.03% | -9.39% | n / a |
Abzène | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 93.25% | n / a |
Agronomie limitée | 475 | 1.04% | 2.99% | -3.60% | -7.62% | -20.78% | n / a |
Thérapeutique contre les allergies | 268 | 0.00% | 0.00% | 0.00% | 5.56% | 14.00% | n / a |
Alliance Pharma | 119 | 0.14% | -4.63% | -7.52% | -10.47% | -8.13% | n / a |
Groupe de soins aux animaux | n / a | 0.00% | 0.00% | 1.40% | 7.43% | 20.56% | n / a |
Anpario | n / a | 0.00% | 2.00% | 4.08% | 9.68% | 0.99% | n / a |
Groupe Aptamer | n / a | -5.45% | 50.41% | 50.41% | 37.88% | -28.06% | n / a |
Aqua Bounty Technologies Inc. (Reg S) | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Arecor Thérapeutique | n / a | 1.28% | 7.59% | -1.25% | -3.32% | -16.72% | n / a |
Argent Biopharma Limited NPV (DI) | n / a | -2.86% | -7.27% | -7.27% | -2.86% | 10.27% | n / a |
AstraZeneca | 123 | 4.99% | 9.20% | 8.72% | 14.16% | 14.07% | n / a |
Groupe Avacta | 461 | -2.43% | -7.92% | -15.81% | -13.16% | -56.45% | n / a |
Titres de référence | n / a | 0.00% | 5.20% | 3.88% | 1.22% | 5.81% | n / a |
Beximco Pharmaceuticals Ltd. RDA (Reg S) | 190 | -2.47% | -2.47% | -2.47% | -9.87% | 1.71% | n / a |
Produits pharmaceutiques Biodexa | 386 | 0.00% | -21.05% | -31.82% | -80.26% | -90.38% | n / a |
Biofrontera SA (DI) | n / a | 0.00% | 1.75% | 1.75% | 1.75% | -1.69% | n / a |
Bioventix | n / a | -1.16% | -3.85% | -5.29% | -1.16% | 4.07% | n / a |
BiVictriX Thérapeutique | n / a | 0.00% | 0.00% | 2.22% | -2.13% | 0.00% | n / a |
BTG | n / a | 0.00% | 0.12% | 0.30% | 0.42% | 0.60% | n / a |
Fonds de découverte C4X | n / a | 0.80% | 11.11% | -1.81% | -28.03% | -29.89% | n / a |
n / a | 0.00% | -2.17% | 0.00% | -11.76% | -47.06% | n / a | |
Groupe de marques de froid | 489 | -3.70% | -31.22% | -18.24% | 5.69% | -48.41% | n / a |
Cizzle Biotechnologie Holdings | n / a | 0.00% | -2.86% | -5.56% | -33.33% | -32.00% | n / a |
Cyprotex | n / a | 0.00% | 0.63% | 0.78% | 1.26% | 8.81% | n / a |
Produits pharmaceutiques Dechra | 121 | 0.00% | 0.16% | 0.26% | 0.68% | 1.90% | n / a |
Deep Verge Plc | 427 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Destin Pharma | 410 | -19.77% | -10.39% | -15.85% | -36.11% | -74.44% | n / a |
Groupe diurne | n / a | 0.00% | 0.00% | 0.00% | 0.55% | 176.46% | n / a |
e-Thérapeutique | n / a | -1.91% | -9.55% | -16.67% | -23.24% | -45.04% | n / a |
EastPharma Ltd RDA (Reg S) | n / a | 0.00% | -14.29% | -60.00% | 9.09% | 9.09% | n / a |
Groupe ECO Santé Animale | n / a | 10.64% | 10.64% | 11.23% | 23.08% | -5.45% | n / a |
Recherche Éden | n / a | 0.00% | -10.31% | -2.79% | -6.45% | -26.27% | n / a |
Ergomé | n / a | 0.00% | 0.15% | 0.30% | 0.90% | 22.14% | n / a |
Evgen Pharma | 304 | 0.00% | 3.23% | 6.67% | -8.57% | -48.39% | n / a |
Faron Pharmaceuticals Oy (DI) | n / a | 2.94% | 11.23% | 2.94% | -7.89% | -54.74% | n / a |
Futura Médical | 479 | -0.84% | 0.00% | -1.39% | -6.58% | 17.16% | n / a |
Genflow Biosciences | n / a | 1.61% | 0.00% | -3.08% | 6.78% | -5.97% | n / a |
Genre | 128 | 1.76% | -1.48% | -3.46% | -4.79% | -26.51% | n / a |
GSK | 129 | 0.61% | 3.95% | 1.04% | -3.05% | 8.20% | n / a |
Gunsynd | 527 | 0.00% | -11.11% | -17.24% | -20.00% | -27.27% | n / a |
GW Pharmaceuticals | n / a | 0.00% | -8.13% | -7.72% | -3.35% | 42.30% | n / a |
Haléon | n / a | 0.21% | 2.83% | 2.20% | 1.26% | 5.85% | n / a |
Hemogenyx Pharma | 340 | -1.55% | -5.27% | -1.86% | -10.82% | -45.41% | n / a |
Hikma Pharmaceuticals | 125 | 2.59% | 3.97% | 2.37% | -0.24% | -0.29% | n / a |
Groupe Horizon Discovery | n / a | 0.00% | 0.00% | -1.34% | -4.90% | 86.36% | n / a |
HUTCHMED (Chine) Limited | 226 | 3.04% | 12.55% | 4.10% | 15.53% | 40.23% | n / a |
Hvivo | n / a | 0.00% | 18.92% | 37.50% | 34.69% | 1.54% | n / a |
Immupharma | 328 | 1.39% | -2.23% | -10.61% | -14.79% | 38.61% | n / a |
Indivior | 314 | -4.95% | -5.58% | -11.83% | -13.21% | 2.57% | n / a |
Capital inspiré | n / a | 0.00% | -0.58% | -0.58% | 0.00% | 12.50% | n / a |
Mexico | n / a | 0.00% | 0.00% | 0.00% | 7.69% | -30.00% | n / a |
LungLife AI, Inc (DI) | n / a | 0.00% | 0.00% | -7.46% | -1.59% | -33.33% | n / a |
Maxcyte Inc (DI/REG S) | 330 | 0.00% | 0.00% | 0.00% | 3.93% | -5.13% | n / a |
Groupe Mereo Biopharma | n / a | 0.00% | -10.17% | -22.06% | -18.46% | -42.39% | n / a |
Motif Biologique | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
N4 Pharma | n / a | 1.82% | -1.18% | 15.86% | 24.44% | -9.19% | n / a |
Nuformix | 322 | -2.70% | -12.20% | -12.20% | -5.26% | -53.85% | n / a |
Okyo Pharma Limited VAN | 403 | 0.00% | -31.71% | -30.00% | -9.68% | -74.07% | n / a |
Ondine Biomedical Inc. VAN (CDI) | n / a | -7.64% | -14.48% | -23.03% | -40.79% | -43.40% | n / a |
OptiBiotix Santé | n / a | 0.00% | -1.39% | -11.25% | -15.48% | -29.70% | n / a |
Ovoca Bio (CDI) | n / a | 0.00% | 13.79% | 50.00% | -2.94% | 3.13% | n / a |
Oxford Biomédica | 125 | -0.92% | 5.61% | 3.34% | 11.25% | 19.09% | n / a |
Holdings d'Oxford Cannabinoid Technologies | n / a | 0.20% | 4.49% | 6.00% | -14.95% | -45.82% | n / a |
Technologies d'Oxford Nanopore | n / a | -4.43% | 3.76% | -9.96% | -21.12% | -32.33% | n / a |
Pfizer Inc. | n / a | 0.00% | 17.46% | 17.46% | 17.46% | 17.46% | n / a |
OJSC Pharmstandard GDR (Reg S) | n / a | 0.00% | -1.75% | 2.89% | -2.00% | 3.16% | n / a |
Pléthore Solutions Holdings | n / a | 0.00% | -11.11% | -11.11% | 9.09% | -33.33% | n / a |
Pharmabeg | n / a | -0.87% | 10.14% | 15.74% | 16.33% | 35.71% | n / a |
Sciences du protéome | 353 | 0.00% | 11.46% | 0.29% | 0.29% | -18.60% | n / a |
PureTech Santé | n / a | 3.76% | 6.27% | 1.61% | -1.12% | 11.25% | n / a |
Pharma quantique | n / a | 0.00% | 2.74% | 2.43% | 2.74% | 52.49% | n / a |
Redx Pharma | 278 | -2.70% | -29.41% | 20.00% | -52.00% | -56.10% | n / a |
Groupe ReNeuron | 394 | 0.00% | 0.00% | 0.00% | 0.00% | -8.78% | n / a |
Sareum Holdings | 594 | -13.52% | -1.40% | 106.86% | 81.90% | -47.25% | n / a |
Fonds Scancell | n / a | 0.00% | 0.52% | -4.95% | -6.34% | -8.57% | n / a |
Thérapeutique du Bouclier | n / a | -11.95% | -20.90% | -25.93% | -41.67% | -81.77% | n / a |
Shire Plc | n / a | 0.00% | 2.63% | 4.36% | 3.42% | 6.88% | n / a |
Thérapeutique du silence | 177 | 0.00% | -1.65% | -0.93% | 5.94% | -9.17% | n / a |
Pharmacie Sinclair | n / a | 0.00% | 0.00% | 0.32% | 0.47% | 45.21% | n / a |
PeauBioThérapeutique | n / a | -1.67% | -6.72% | -9.05% | -16.17% | -28.66% | n / a |
Skyepharma | n / a | 0.00% | -1.94% | -4.47% | -6.39% | 17.35% | n / a |
Source BioSciences | n / a | 0.00% | -4.11% | -1.41% | -1.41% | 2.19% | n / a |
Sommet Thérapeutique | n / a | 0.00% | -2.38% | -12.77% | -2.38% | -6.82% | n / a |
Synairgène | 510 | 0.00% | -3.03% | -11.11% | 23.79% | 9.50% | n / a |
Taïwan | n / a | 0.00% | -30.00% | 59.09% | -46.15% | -72.00% | n / a |
Sciences de la vie de Tiziana | n / a | 0.00% | 11.43% | 12.50% | 7.34% | -7.87% | n / a |
Valirx | 435 | -6.28% | -6.28% | -11.42% | -16.02% | -33.33% | n / a |
Groupe Vectura | 139 | 0.00% | 0.12% | -0.12% | 0.00% | 6.74% | n / a |
Verici DX | 429 | -0.65% | -3.75% | -0.65% | -16.76% | -18.95% | n / a |
Vernalis SA | n / a | 0.00% | 0.49% | 0.33% | 0.82% | -4.19% | n / a |
Vérone Pharma | n / a | 0.00% | 4.76% | 4.76% | -15.38% | -24.14% | n / a |
Verseon Corporation (DI/REG S) | n / a | 0.00% | 96.72% | 73.91% | -48.94% | -67.74% | n / a |
Verseon Corporation (Reg S Cat 3) | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Santé de Yourgene | n / a | 0.00% | 0.98% | 0.98% | 5.10% | 139.53% | n / a |